Difference between revisions of "Template:Lipid signaling"
Jump to navigation
Jump to search
imported>Medgirl131 m |
imported>Boghog (add child navboxes and eliminated distracting bolding) |
||
| Line 6: | Line 6: | ||
| group1 = Extracellular | | group1 = Extracellular | ||
| − | | | + | | list1 = {{Navbox|child |
| − | + | ||
| + | | group1 = {{nobold|''Eicosanoids''}} | ||
| + | | list1 = | ||
| + | |||
| + | * ''Classic:'' [[Eoxin]]s; | ||
* [[Leukotriene]]s ([[Leukotriene receptor|LTR]]) | * [[Leukotriene]]s ([[Leukotriene receptor|LTR]]) | ||
* [[Prostacyclin]] ([[Prostacyclin receptor|IPR]]) | * [[Prostacyclin]] ([[Prostacyclin receptor|IPR]]) | ||
* [[Prostaglandin]]s ([[Prostaglandin receptor|PGR]]) | * [[Prostaglandin]]s ([[Prostaglandin receptor|PGR]]) | ||
| − | * [[Thromboxane]] ([[Thromboxane receptor|TXR]]) | + | * [[Thromboxane]] ([[Thromboxane receptor|TXR]]) |
| + | * ''Nonclassic:'' [[Epoxyeicosatrienoic acid|EET]]s | ||
* [[Endocannabinoid]]s ([[Cannabinoid receptor|CBR]]) | * [[Endocannabinoid]]s ([[Cannabinoid receptor|CBR]]) | ||
* [[Epi-lipoxin]]s ([[Formyl peptide receptor 2|FPR2]]) | * [[Epi-lipoxin]]s ([[Formyl peptide receptor 2|FPR2]]) | ||
| Line 18: | Line 23: | ||
* [[Lipoxin]]s ([[Formyl peptide receptor 2|FPR2]]) | * [[Lipoxin]]s ([[Formyl peptide receptor 2|FPR2]]) | ||
* [[Oxoeicosanoid]]s ([[Oxoeicosanoid receptor|OXER]]) | * [[Oxoeicosanoid]]s ([[Oxoeicosanoid receptor|OXER]]) | ||
| − | * [[Resolvin]]s ([[Formyl peptide receptor 2|FPR2]]) | + | * [[Resolvin]]s ([[Formyl peptide receptor 2|FPR2]]) |
| − | * [[Sphingosine-1-phosphate|S1P]] ([[Sphingosine-1-phosphate receptor|S1PR]]) | + | |
| + | | group2 = {{nobold|''Lysophospholipids''}} | ||
| + | | list2 = | ||
| + | * [[Lysophosphatidic acid|LPA]] ([[Lysophosphatidic acid receptor|LPAR]]) | ||
| + | * [[Sphingosine-1-phosphate|S1P]] ([[Sphingosine-1-phosphate receptor|S1PR]]) | ||
| + | |||
| + | | group3 = {{nobold|''Steroids''}} | ||
| + | | list3 = | ||
| + | * [[Bile acid]]s ([[G protein-coupled bile acid receptor|GPBAR]]) | ||
* [[Neurosteroid]]s | * [[Neurosteroid]]s | ||
| − | * [[Pheromone]]s ([[Vomeronasal receptor|VNR]]) | + | * [[Pheromone]]s ([[Vomeronasal receptor|VNR]]) |
| + | |||
| + | | group4 = {{nobold|''Others''}} | ||
| + | | list4 = | ||
| + | * [[Platelet-activating factor|PAF]] ([[Platelet-activating factor receptor|PAFR]]) | ||
* [[Retinal]] ([[Rhodopsin|RHO]]) | * [[Retinal]] ([[Rhodopsin|RHO]]) | ||
| − | + | }} | |
| group2 = Intracellular | | group2 = Intracellular | ||
| list2 = {{Navbox subgroup | | list2 = {{Navbox subgroup | ||
| Line 30: | Line 47: | ||
| group1 = [[Nuclear receptor]] | | group1 = [[Nuclear receptor]] | ||
| list1 = | | list1 = | ||
| − | * | + | * ''Steroids:'' ''Sex steroids:'' [[Androgen]]s ([[Androgen receptor|AR]]) |
* [[Estrogen]]s ([[Estrogen receptor|ER]]) | * [[Estrogen]]s ([[Estrogen receptor|ER]]) | ||
* [[Progestogen]]s ([[Progesterone receptor|PR]]); ''Corticosteroids:'' [[Glucocorticoid]]s ([[Glucocorticoid receptor|GR]]) | * [[Progestogen]]s ([[Progesterone receptor|PR]]); ''Corticosteroids:'' [[Glucocorticoid]]s ([[Glucocorticoid receptor|GR]]) | ||
* [[Mineralocorticoid]]s ([[Mineralocorticoid receptor|MR]]); ''Others:'' [[Bile acid]]s ([[Farnesoid X receptor|FXR]]) | * [[Mineralocorticoid]]s ([[Mineralocorticoid receptor|MR]]); ''Others:'' [[Bile acid]]s ([[Farnesoid X receptor|FXR]]) | ||
| − | * [[Calcitriol]] ([[Vitamin D receptor|VDR]]); | + | * [[Calcitriol]] ([[Vitamin D receptor|VDR]]); ''Others:'' [[Eicosanoid]]s ([[Peroxisome proliferator-activated receptor|PPAR]]) |
* [[Free fatty acid]]s ([[Peroxisome proliferator-activated receptor|PPAR]]) | * [[Free fatty acid]]s ([[Peroxisome proliferator-activated receptor|PPAR]]) | ||
* [[Retinoic acid]] ([[Retinoic acid receptor|RAR]], [[Retinoid X receptor|RXR]]) | * [[Retinoic acid]] ([[Retinoic acid receptor|RAR]], [[Retinoid X receptor|RXR]]) | ||
| Line 40: | Line 57: | ||
| group2 = [[Second messenger system|Second messenger]] | | group2 = [[Second messenger system|Second messenger]] | ||
| list2 = | | list2 = | ||
| − | * | + | * ''General:'' [[Arachidonic acid]] |
* [[Diacylglycerol|DAG]] ([[Protein kinase C|PKC]], [[TRPC]]) | * [[Diacylglycerol|DAG]] ([[Protein kinase C|PKC]], [[TRPC]]) | ||
* [[Inositol trisphosphate|IP<sub>3</sub>]] ([[Inositol trisphosphate receptor|IP<sub>3</sub>R]], [[Ryanodine receptor|RyR]]) | * [[Inositol trisphosphate|IP<sub>3</sub>]] ([[Inositol trisphosphate receptor|IP<sub>3</sub>R]], [[Ryanodine receptor|RyR]]) | ||
* [[Phosphatidic acid]] | * [[Phosphatidic acid]] | ||
| − | * | + | * ''Phosphoinositides:'' [[Phosphatidylinositol 4,5-bisphosphate|PIP<sub>2</sub>]] ([[Inward-rectifier potassium ion channel|IRK]]s) |
* [[Phosphatidylinositol (3,4,5)-trisphosphate|PIP<sub>3</sub>]] ([[Protein kinase B|PKB/Akt]], [[Bruton's tyrosine kinase|Btk]], [[Phosphoinositide-dependent kinase-1|PDPK1]]) | * [[Phosphatidylinositol (3,4,5)-trisphosphate|PIP<sub>3</sub>]] ([[Protein kinase B|PKB/Akt]], [[Bruton's tyrosine kinase|Btk]], [[Phosphoinositide-dependent kinase-1|PDPK1]]) | ||
| − | * [[Phosphatidylinositol 3,4-bisphosphate|PtdIns(3,4)P<sub>2</sub>]] ([[Protein kinase B|PKB/Akt]], [[Phosphoinositide-dependent kinase-1|PDPK1]]); | + | * [[Phosphatidylinositol 3,4-bisphosphate|PtdIns(3,4)P<sub>2</sub>]] ([[Protein kinase B|PKB/Akt]], [[Phosphoinositide-dependent kinase-1|PDPK1]]); ''Sphingolipids:'' [[Ceramide-1-phosphate|C1P]] |
* [[Ceramide]] ([[Ceramide-activated protein phosphatase|CAPP]]s, [[KSR1]], [[Protein kinase C zeta type|PKCζ]], [[Cathepsin D|CTSD]]) | * [[Ceramide]] ([[Ceramide-activated protein phosphatase|CAPP]]s, [[KSR1]], [[Protein kinase C zeta type|PKCζ]], [[Cathepsin D|CTSD]]) | ||
* [[Glucosylceramide]]s | * [[Glucosylceramide]]s | ||
| Line 54: | Line 71: | ||
| group3 = Precursors | | group3 = Precursors | ||
| − | | | + | | list3 = {{Navbox|child |
| − | + | ||
| + | | group1 = {{nobold|''General''}} | ||
| + | | list1 = | ||
| + | * [[Fatty acid]]s ([[Omega-3 fatty acid|ω-3]], [[Omega-6 fatty acid|ω-6]]) | ||
| + | |||
| + | | group2 = {{nobold|''Steroids''}} | ||
| + | | list2 = | ||
| + | * [[Squalene]] | ||
* [[Lanosterol]] | * [[Lanosterol]] | ||
* [[Cholesterol]] | * [[Cholesterol]] | ||
| − | + | }} | |
| belowstyle = padding: 0px; | | belowstyle = padding: 0px; | ||
| below = {{Signal transduction navs}} | | below = {{Signal transduction navs}} | ||
Revision as of 16:10, 6 July 2015